Title

#RecognizeAndOptimize: Pediatrics and adolescent HIV

Code

WEAB02

Session Type

Oral Abstract SessionTrack B – Clinical Science

Venue

Casa del Diezmo 1 y 2

Date Time

Wednesday 24 July, 14:30 - 16:00

Co-Chairs:

Vanessa Rouzier, GHESKIO - Haitian Global Health Alliance, Haiti
Lee Fairlie, Wits Reproductive Health & HIV Institute (Wits RHI), Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, South Africa

14:30 WEAB0201	Describing the characteristics and long-term outcomes of adolescents living with perinatally acquired HIV in the IeDEA-Southern Africa Collaboration: 2004-2017 Priscilla Ruvimbo Tsondai, University of Cape Town, South Africa	Abstract PDF

14:45 WEAB0202	Predictors of treatment failure, time to switch and reasons for switching to second line antiretroviral therapy in HIV-infected children receiving first line anti-retroviral therapy Alemseged Beyene, Addis Ababa University, Ethiopia	Abstract Slides

15:00 WEAB0203	Dolutegravir containing regimens may need optimization for African youth failing ART Vinie Kouamou, University of Zimbabwe College of Health Sciences, Parirenyatwa Hospital, Zimbabwe	Abstract Slides

15:15 WEAB0204	Cognitive function among cART-treated children and adolescents with HIV in Zambia: Results from the HIV-associated neurocognitive disorders in Zambia (HANDZ) study Sylvia Mwanza-Kabaghe, The University of Zambia, Zambia	Abstract Slides

15:30 WEAB0205	Response to direct acting antivirals in vertically HIV/HCV co-infected youths Itzíar Carrasco, IiSGM- Gregorio Marañon University Hospital, Spain	Abstract